(Q43648942)

25 November 2017

Effects of sertraline on regional neuropeptide concentrations in olfactory bulbectomized rats (English)

1 reference

25 November 2017

1 reference

Bissette G

1

1 reference

PubMed ID

11420095

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Pharmacology, Biochemistry and Behavior

25 November 2017

1 reference

25 November 2017

69

1 reference

25 November 2017

269-281

1 reference

25 November 2017

1-2

1 reference

The influence of hGRF, CRF, TRH and LHRH on SRIF release from median eminence fragments.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Hypothalamic-pituitary-adrenal axis and suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Olfactory bulbectomy alters alpha-1 acid glycoprotein levels in rat plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Elevation of immunoreactive CSF TRH in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Modification of pentobarbital-induced sedation by natural and synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Corticosterone, choline acetyltransferase and noradrenaline levels in olfactory bulbectomized rats in relation to changes in passive avoidance acquisition and open field activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Short-lasting behavioural effects of thyrotropin-releasing hormone in depressed women: results of placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Effects of olfactory bulbectomy and domicile on stress-induced corticosterone release in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

The effect of psychoactive drugs on plasma corticosterone levels and behaviour in the bulbectomised rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Olfactory projection systems, drugs and behaviour: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Basal plasma corticosterone level after bilateral selective lesions of the olfactory pathways in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Effects of acute and chronic desipramine treatment on somatostatin receptors in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Chronic parenteral antidepressant treatment in rats: unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory/limbic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Blunted aldosterone and ACTH release after human CRH administration in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Colocalization of peptide- and tyrosine hydroxylase-like immunoreactivities with Fos-immunoreactive neurons in rat central amygdaloid nucleus after immobilization stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Animal models of depression: parallels and correlates to severe depression in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Long-term effects of cysteamine on cognitive and locomotor behavior in rats: relationship to hippocampal glial pathology and somatostatin levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Repeated administration of antidepressant drugs reduces regional somatostatin concentrations in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Corticotropin-releasing factor administered intraventricularly to rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

The olfactory bulbectomized rat as a model of depression: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Effects of subconvulsive and repeated electroconvulsive shock on thyrotropin-releasing hormone in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Neuroanatomical connections between corticotropin-releasing factor (CRF) and somatostatin (SRIF) nerve endings and thyrotropin-releasing hormone (TRH) neurons in the paraventricular nucleus of rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Increase in levels and ex vivo release of thyrotrophin-releasing hormone (TRH) in specific regions of the CNS of the rat by chronic treatment with antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

An investigation of serotonergic involvement in the regulation of ACTH and corticosterone in the olfactory bulbectomized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Changes of cerebral vasoactive intestinal polypeptide- and somatostatin-like immunoreactivity induced by noise and whole-body vibration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Repeated electroconvulsive shock increases glial fibrillary acidic protein, ornithine decarboxylase, somatostatin and cholecystokinin immunoreactivities in the hippocampal formation of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

The effect of repeated administration of antidepressant drugs on the thyrotropin-releasing hormone (TRH) content of rat brain structures

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Serotonin modulates the levels of mRNAS coding for thyrotropin-releasing hormone and preprotachykinin by different mechanisms in medullary raphe neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Cerebrospinal fluid somatostatin and psychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Chemical and surgical lesions of rat olfactory bulb: changes in thyrotropin-releasing hormone and other systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

The effects of antidepressants on the thyroid axis in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Chronic administration of tricyclic antidepressants suppresses hypothalamo-pituitary-adrenocortical activity in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Effects of intracerebroventricularly administered somatostatin on passive avoidance, shuttle-box behaviour and open-field activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

Prolonged c-Jun expression in the basolateral amygdala following bulbectomy: possible implications for antidepressant activity and time of onset

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900513-5

7 January 2021

10.1016/S0091-3057(01)00513-5

Identifiers

DOI

1 reference

25 November 2017

1 reference

PubMed ID

11420095